tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

APRE Stock Latest News

Aprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
Press ReleasesAprea Therapeutics Announces Presentations on its Next Generation WEE1 Inhibitor, APR-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, at AACR Annual Meeting 2024
9d ago
APRE
Aprea Therapeutics files to sell 4.39M shares of common stock for holders
PremiumThe Fly
Aprea Therapeutics files to sell 4.39M shares of common stock for holders
16d ago
APRE
Aprea Therapeutics price target raised to $11 from $9 at Wedbush
PremiumThe Fly
Aprea Therapeutics price target raised to $11 from $9 at Wedbush
23d ago
APRE
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
PremiumPress Releases
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
24d ago
APRE
Aprea Therapeutics sees cash runway into 3Q25
PremiumThe Fly
Aprea Therapeutics sees cash runway into 3Q25
24d ago
APRE
Aprea Therapeutics reports Q4 EPS (92c), consensus (77c)
PremiumThe FlyAprea Therapeutics reports Q4 EPS (92c), consensus (77c)
24d ago
APRE
APRE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
APRE Upcoming Earnings Report: What to Expect?
25d ago
APRE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ACAD
APRE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
MRK
APRE
Aprea Therapeutics Secures Funding and Advances Drug Pipeline
PremiumCompany Announcements
Aprea Therapeutics Secures Funding and Advances Drug Pipeline
1M ago
8K
APRE
Aprea Therapeutics enters private placement financing for up to $34M
PremiumThe Fly
Aprea Therapeutics enters private placement financing for up to $34M
1M ago
APRE
Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers
PremiumPress Releases
Aprea Therapeutics Announces FDA Clearance of IND for APR-1051, its Next Generation WEE1 Kinase Inhibitor for Cyclin E Overexpressing Cancers
1M ago
APRE
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
PremiumPress ReleasesAprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
1M ago
APRE
Aprea Therapeutics announces FDA clearance of IND for APR-1051
PremiumThe Fly
Aprea Therapeutics announces FDA clearance of IND for APR-1051
1M ago
APRE
Aprea Therapeutics Announces Acceptance of Abstracts at American Association of Cancer Research Annual Meeting 2024
PremiumPress Releases
Aprea Therapeutics Announces Acceptance of Abstracts at American Association of Cancer Research Annual Meeting 2024
1M ago
APRE
Aprea Therapeutics Updates Corporate Presentation Materials
PremiumCompany Announcements
Aprea Therapeutics Updates Corporate Presentation Materials
2M ago
8K
APRE
Aprea Therapeutics announces IND application for APR-1051
PremiumThe Fly
Aprea Therapeutics announces IND application for APR-1051
2M ago
APRE
Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor
PremiumPress Releases
Aprea Therapeutics Announces Submission of IND Application for APR-1051, a Next Generation WEE1 Kinase Inhibitor
2M ago
APRE
Aprea Therapeutics to Present at DDR Inhibitors Summit 2024
PremiumPress Releases
Aprea Therapeutics to Present at DDR Inhibitors Summit 2024
3M ago
APRE
Aprea Therapeutics Signs Sales Agreement with HCW
PremiumMarket NewsAprea Therapeutics Signs Sales Agreement with HCW
3M ago
8K
APRE
Aprea Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Aprea Therapeutics files $150M mixed securities shelf
3M ago
APRE
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
PremiumPress Releases
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
4M ago
APRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >